Pyrexia, commonly known as fever, is a prevalent symptom in clinical practice, often indicating an underlying pathophysiological process. It is vital for clinicians to understand its mechanisms, differential diagnosis, and management strategies.
Pyrexia is a complex physiological response to a pyrogenic stimulus, often an infection or inflammation. The hypothalamus, acting as the body's thermostat, increases the set body temperature, leading to fever. Understanding this process is crucial in identifying the cause and formulating a treatment plan.
Identifying the cause of pyrexia is a significant challenge. It could be infectious, inflammatory, neoplastic, or even drug-induced. A thorough history, physical examination, and appropriate investigations are essential to pinpoint the etiology. Special attention should be given to 'fever of unknown origin', a situation where the cause remains elusive even after extensive evaluation.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics like paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptomatic management. However, the decision to treat fever should be individualized, considering the potential benefits of fever in fighting infections.
Antipyretics play a significant role in managing discomfort associated with fever. However, their use should be judicious, considering their potential side effects. Furthermore, the use of antipyretics has not been shown to prevent febrile seizures, a common concern among caregivers.
Pyrexia is a common clinical symptom with a wide array of potential causes. A comprehensive understanding of its mechanisms, causes, and management strategies is essential for effective patient care. While antipyretics provide symptomatic relief, the focus should always be on identifying and treating the underlying cause.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation